Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06138236 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides

Study acronym: PFESWTCP
StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 8, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 31, 2024 to Dec 31, 2025v4
  2. Primary completion date: Mar 31, 2024 to Dec 31, 2024
    • Study completion date: Jun 30, 2024 to Dec 31, 2024
    v3
  3. Primary endpoints revised (4)
    • Primary completion date: Dec 31, 2023 to Mar 31, 2024
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients suffering from Plantar Fasciitis were randomized into three groups: the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.
Trial Details
NCT Number NCT06138236
Lead Sponsor Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Conditions
(from sponsor)		 Plantar Fascitis
Enrollment 84 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov